Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Rapid Micro Biosystems, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −11 vs. Q4 2022
- Shares held
- 22.9M
- −1.65M (−6.7%) vs. Q4 2022
- Total value
- $29.9M
- +$2.18M (+7.9%) vs. Q4 2022
- New holders
- 1
- 6 more added
- Sold out
- 12
- 12 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 81 | $106 | 0.00% | +2+2.5% | Added |
| Advisory Services Network, LLC | 100 | $131 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 211 | $276 | 0.00% | −5,503−96.3% | Reduced |
| Tower Research Capital LLC (TRC) | 4,570 | $6.00K | 0.00% | −5,831−56.1% | Reduced |
| Morgan Stanley | 10,208 | $13.4K | 0.00% | −3,666−26.4% | Reduced |
| Ergoteles LLC | 13,624 | $17.8K | 0.00% | −16,950−55.4% | Reduced |
| Schonfeld Strategic Advisors LLC | 15,000 | $19.6K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 15,661 | $20.5K | 0.00% | +15,523+11,248.6% | Added |
| Northern Trust Corp | 21,515 | $28.2K | 0.00% | 00.0% | Unchanged |
| Parkwood LLC | 24,511 | $32.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 26,074 | $34.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 35,057 | $46.0K | 0.00% | −12,496−26.3% | Reduced |
| Renaissance Technologies LLC | 40,700 | $53.0K | 0.00% | +40,700 | New |
| Manufacturers Life Insurance Company, The | 53,117 | $69.6K | 0.00% | −27−0.1% | Reduced |
| TD Asset Management Inc | 58,496 | $76.6K | 0.00% | −58,688−50.1% | Reduced |
| Geode Capital Management, LLC | 96,648 | $126.6K | 0.00% | −1,273−1.3% | Reduced |
| Rhenman & Partners Asset Management AB | 127,152 | $165.3K | 0.02% | −172,848−57.6% | Reduced |
| Bridgeway Capital Management, LLC | 138,000 | $180.8K | 0.00% | 00.0% | Unchanged |
| Advent International Corp | 577,777 | $756.9K | 0.01% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 699,664 | $916.6K | 1.20% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 700,000 | $917.0K | 0.00% | −16,209−2.3% | Reduced |
| Vanguard Group Inc | 729,600 | $955.8K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 760,438 | $997.0K | 0.00% | −40,066−5.0% | Reduced |
| Glenview Capital Management, LLC | 818,288 | $1.07M | 0.03% | +7,897+1.0% | Added |
| Goldman Sachs Group Inc | 944,340 | $1.24M | 0.00% | −89,001−8.6% | Reduced |
| BlackRock Inc. | 1,027,060 | $1.35M | 0.00% | +1,638+0.2% | Added |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $1.36M | 21.45% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,455,161 | $1.91M | 0.00% | +1,453,885+113,940.8% | Added |
| Kennedy Lewis Management LP | 4,939,931 | $6.47M | 17.03% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $11.0M | 1.38% | 00.0% | Unchanged |
| Resources Management Corp | 50,029 | – | – | +49,529+9,905.8% | Added |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −2,194,185−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −187,617−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −161,400−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −123,845−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −56,935−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −29,934−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,683−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,959−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Arena Investors LP | 0 | $0 | 0.00% | −1,965−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −593−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −104−100.0% | Sold out |